Sarsia
Biotechnology · Venture Capital
Overview
Sarsia is a Norwegian seed and early-stage venture capital investor. It backs research-based startups in life sciences, medical technology and other technology sectors, with a strong connection to universities and research institutions in western Norway. The firm is headquartered in Bergen, Norway.
Investor profile
Venture capitalInvestments
36
18 of them startups
Hiring now
1
1 open roles
Exits
1
Focusshare of its companies
Health Care 33%Energy & Utilities 25%Hardware 17%Transportation & Logistics 13%Biotechnology 13%Cybersecurity 13%Robotics 8%Information Technology 8%
Where its companies are
Norway 28%United Kingdom 3%Finland 3%Sweden 3%
Stage of its companies
Pre-seed & seed 100%
Its companies, the freshest money firstAll 36 investments
CetasolSeed $2.2M · 2 yr ago
Elekt1 role
Joulia
Enua
Nisonic
Windsim
Seafarm Solutions AS
ScreenCancer UK Ltd
BerGenBio
Prophylix
Oculaudio
XSENSFLOW
Co-investorscompanies they hold together
Similar investorstheir companies share markets and countries
Sources: its portfolio page, read Nov 3
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors

InvestinorVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Bergen
Norway
HQ

Ysios Capital
Astanor
Suma Capital
Explorer Investments
Value4Capital
Magnus Jepson
THEFACTORY AS
Idekapital
Charge Incubator
Alliance Venture Capital
Askeladden & Co
Skyfall Ventures